TY - JOUR
T1 - Activation of a cryptic splice site of PTEN and loss of heterozygosity in benign skin lesions in Cowden disease
AU - Trojan, Joerg
AU - Plotz, Guido
AU - Brieger, Angela
AU - Raedle, Jochen
AU - Meltzer, Stephen J.
AU - Wolter, Manfred
AU - Zeuzem, Stefan
PY - 2001/12
Y1 - 2001/12
N2 - Cowden disease is an autosomal dominant syndrome characterized by facial trichilemmomas, acral keratoses, papillomatous papules, mucosal lesions, and an increased risk for breast and nonmedullary thyroid cancer. Here, we describe a novel PTEN splicing site mutation in a family with classical Cowden disease and we studied benign skin lesions typical for Cowden disease for loss of heterozygosity. We found a PTEN IVS2 + 1G > A 5′-splicing acceptor mutation resulting in activation of a cryptic splice site. Activation of this cryptic splice site is predicted to result in a frameshift with a premature stop codon, thus disrupting the phosphatase core motif of PTEN. Loss of heterozygosity analysis of two trichilemmomas, one fibroma, and three acanthomas of the index patient demonstrated loss of heterozygosity at the PTEN locus in four of these lesions. In conclusion, our data demonstrate that a PTEN splicing site mutation causes activation of a cryptic splice site, which results in aberrant transcripts.
AB - Cowden disease is an autosomal dominant syndrome characterized by facial trichilemmomas, acral keratoses, papillomatous papules, mucosal lesions, and an increased risk for breast and nonmedullary thyroid cancer. Here, we describe a novel PTEN splicing site mutation in a family with classical Cowden disease and we studied benign skin lesions typical for Cowden disease for loss of heterozygosity. We found a PTEN IVS2 + 1G > A 5′-splicing acceptor mutation resulting in activation of a cryptic splice site. Activation of this cryptic splice site is predicted to result in a frameshift with a premature stop codon, thus disrupting the phosphatase core motif of PTEN. Loss of heterozygosity analysis of two trichilemmomas, one fibroma, and three acanthomas of the index patient demonstrated loss of heterozygosity at the PTEN locus in four of these lesions. In conclusion, our data demonstrate that a PTEN splicing site mutation causes activation of a cryptic splice site, which results in aberrant transcripts.
KW - Genes, suppressor, tumor
KW - Germline mutation
KW - Hamartoma syndrome, multiple
KW - Keratosis
KW - Loss of heterozygosity
KW - RNA splicing
UR - http://www.scopus.com/inward/record.url?scp=0035675654&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035675654&partnerID=8YFLogxK
U2 - 10.1046/j.0022-202x.2001.01954.x
DO - 10.1046/j.0022-202x.2001.01954.x
M3 - Article
C2 - 11886535
AN - SCOPUS:0035675654
SN - 0022-202X
VL - 117
SP - 1650
EP - 1653
JO - Journal of Investigative Dermatology
JF - Journal of Investigative Dermatology
IS - 6
ER -